Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL

Autor:	Reed, S, Li, Y, Dakin, H, Becker, F, Leal, J, Gustavson, S, Kartman, B, Wittbrodt, E, Mentz, R, Pagidipati, N, Bethel, M, Gray, A, Holman, R, Hernandez, A
Rok vydání:	2018
DOI:	10.1007/s00125-018-4693-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______1064::72d94f03846a992ed800b1fc95b09bf9 https://doi.org/10.1007/s00125-018-4693-0 Zobrazit plný text záznamu